Clicky

Intelligence » Lymphoma » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Sunday, December 10, 2017 -- (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

Sunday, December 10, 2017 -- (Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

Wednesday, December 13, 2017 -- An observational study by researchers at Mayo Clinic has found that increasing physical activity not only decreased the risk of death from all causes but also decreased the risk of death specifically from lymphoma.

Sunday, December 10, 2017 -- (MENAFN Editorial) CAMBRIDGE, England-Sunday, December 10th 2017 ()-- AstraZeneca and Acerta Pharma, its haematology research and development centre of excellence, today present...

Monday, December 11, 2017 -- (MENAFN Editorial) TOKYO and BASKING RIDGE, N.J. and MUNICH, Dec. 11, 2017 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that prelimin...

Saturday, December 09, 2017 -- The median time to response (TRR) was 1.9 months. The median duration of response (DoR) was not reached, though the 12-month DoR rate was 72% (95% CI, 62-80%).

Monday, December 11, 2017 -- Acalabrutinib treatment provided a high rate of durable responses and a favourable safety profile in patients with relapsed or refractory mantle cell lymphoma. These findings suggest an important role for acalabrutinib in the treatment of this disease population.

Tuesday, December 12, 2017 -- The FDA has granted accelerated approval to acalabrutinib (Calquence®) for the treatment of adults with mantle cell lymphoma whose cancer has progressed after receiving at least one prior therapy.

Monday, December 11, 2017 -- Lower combined risk of progression, death, or noncomplete response with A+AVD

Monday, December 11, 2017 -- Workshop to be held on Monday, December 11th at 12:00 pm EST December 11, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep...

Saturday, December 09, 2017 -- CAMBRIDGE, Mass. and BEIJING, China, Dec. 09, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and...

Saturday, December 09, 2017 -- La Chaux-de-Fonds, Switzerland, Dec. 09, 2017 -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for RP6530 (tenalisib), the Company’s...

Wednesday, December 13, 2017 -- A blood test using infrared spectroscopy can be used to diagnose two types of cancer...

Monday, December 11, 2017 -- With breakthrough designation from the FDA and priority medicine status in the EU, expectations for Roche’s antibody-drug conjugate for non-Hodgkin lymphoma polatuzumab vedotin are running pretty high. Phase 2 data presented at ASH 2017 suggests that optimism could be justified.

Related pages


salvia tabletswhit care skin creamlevothyroxine uses and side effectstab oleanztablet.qutipin 25mg এর কাজ কিmoxicamclot tabletnor qd reviewsmenthol zinc oxidecomposition of polio vaccinecomposition of antacidinfanrix package insertdemazin south africadynapar injection side effectstrispharmazalain creampolytrim solutionmicrodox lbx का उपयोग करता हैinosiplex side effectscanesten fungal creamanalgesic muscle relaxantdidivirflozen aa tablet uses in hindiapo clobazamvitagreat tablets for pregnancyvebalonebio cimetidine tabletsfasyginmucocil सिरपhalobetasol propionate cream usesstilbestrol useseconazole nitrate cream reviewswhat is the use of m2 tone syrupherudoidsilybondolo 650 compositionveganinwhat is celestaminelimnanthes alba meadowfoam seed oilzinnat tablets 250mgbutambenmesulid suspensionhow to use scaboma lotionresistal p tabletvb7side effect of glimepiridetheragran m reviewsserdolectuses of amidesnorflaxnizral shampooquinoxkidney bean extract side effectsnixoderm ingredientscholecalciferol 60000leucovorin tabletsyrup nootropilchlorohistol antihistamineserpina himalayapantop dsr side effectsdicyclomine hcl 20mgtiostattakepron 30 lansoprazoleconcor plus tabletprimolut n 5mg tabletslithotabsslimit capsulesventab tabletrefzil o 250 mg usesbenzemul applicationtolonium chloride